Home
About
Overview
Sharing Data
ORCID
Help
History (17)
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial.
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Clayton, Stephen
A 2014 update on the management of patients with systemic lupus erythematosus.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A 2014 update on the management of patients with systemic lupus erythematosus.
A 2014 update on the management of patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2014 Oct; 44(2):e1-2.
View in:
PubMed
subject areas
Biological Factors
Humans
Lupus Erythematosus, Systemic
Risk Factors
authors with profiles
Joan Merrill